Accelerate Diagnostics Annual Income Statement (NASDAQ:AXDX)

Add to My Stocks
$21.85 $0.8 (3.53%) AXDX stock closing price Jan 17, 2017 (Closing)

Fundamental analysis of AXDX stock involves analyzing its financial statements, apart from checking the Accelerate Diagnostics stock price The income statement gives the investor an understanding of the topline and bottomline numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the AXDX income statement also itemizes revenue, operating expenses, and profits for a quarter or year and reflects a YoY revenue growth of $0.02M when compared to the same period in the past. The operating expenses (also check: Accelerate Diagnostics assets and Accelerate Diagnostics free cash flow) as shown in the Accelerate Diagnostics profit and loss statement 2015 total to $45.69M. This line item has increased from $31.63M compared with last year. Accelerate Diagnostics revenue for 2015 is $0.14M. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Accelerate Diagnostics Net Sales or Revenues
0.14M0.12M0.04M-1.12M2.24M1.26M0.47M0.18M0.21M
Cost Of Goods Sold (COGS)-------0.01M0.05M0.04M
Accelerate Diagnostics Gross Profit
0.14M0.12M0.04M-1.12M2.24M1.26M0.46M0.12M0.17M
Research & Development Expense26.02M20.05M10.67M-0.45M0.5M0.74M0.88M0.99M2.15M
Selling General & Admin Expense17.88M10.69M4.31M-0.81M0.87M0.93M1.01M0.93M0.9M
Income Before Depreciation Depletion Amortization-43.75M-30.62M-14.93M--0.15M0.87M-0.4M-1.43M-1.8M-2.88M
Depreciation Depletion Amortization1.79M0.89M0.37M-0.25M0.26M0.27M0.29M0.31M0.31M
Non Operating Income0.07M0.06M0.02M-0.03M0.02M-0.03M0.04M0.19M0.17M
Interest Expense0.02M0.01M--------
Accelerate Diagnostics Pretax Income
-45.49M-31.46M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M-3.03M
Provision for Income Taxes--0.52M--------
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M-3.03M
Extraordinary Items & Discontinued Operations----------
Accelerate Diagnostics Net Income (Profit/Loss)
-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M-3.03M
Average Shares used to compute Diluted EPS45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M10.1M
Average Shares used to compute Basic EPS45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M10.1M
Income Before Nonrecurring Items-45.5M-30.93M-15.28M-5.31M-0.38M0.64M-0.71M-1.68M-1.92M-3.03M
Income from Nonrecurring Items----------
Accelerate Diagnostics Earnings Per Share Basic Net
-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19-0.30
Accelerate Diagnostics Earnings Per Share Diluted Net
-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19-0.30
EPS Diluted Before Nonrecurring Items-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19-0.30
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

1:25
AXDX
It is very helpful to read a report on Accelerate Diagnostics stock analysis. An investor must check the following items in an income statement:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AXDX stock has a topline or revenue of $0.14M for 2015 as per this Accelerate Diagnostics revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Accelerate Diagnostics try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called statement of revenue and expense. The financials along with Accelerate Diagnostics historical stock prices provides a lot of details about the firm. .

Accelerate Diagnostics Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
5089.0636
Operating margin
-87050
Net profit margin
-86500
Dividend yield
0%